CtIP silencing as a novel mechanism of tamoxifen resistance in breast cancer. [electronic resource]
Producer: 20080304Description: 1285-95 p. digitalISSN:- 1541-7786
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carrier Proteins -- genetics
- Cell Line, Tumor
- Disease-Free Survival
- Down-Regulation
- Drug Resistance, Neoplasm -- genetics
- Endodeoxyribonucleases
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Silencing
- Growth Inhibitors -- metabolism
- Humans
- Nuclear Proteins -- genetics
- Tamoxifen -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.